Panacea Biotec Limited

NSEI:PANACEABIO Stock Report

Market Cap: ₹25.9b

Panacea Biotec Balance Sheet Health

Financial Health criteria checks 5/6

Panacea Biotec has a total shareholder equity of ₹8.3B and total debt of ₹215.7M, which brings its debt-to-equity ratio to 2.6%. Its total assets and total liabilities are ₹12.4B and ₹4.1B respectively.

Key information

2.6%

Debt to equity ratio

₹215.70m

Debt

Interest coverage ration/a
Cash₹1.77b
Equity₹8.29b
Total liabilities₹4.14b
Total assets₹12.43b

Recent financial health updates

Recent updates

There's No Escaping Panacea Biotec Limited's (NSE:PANACEABIO) Muted Revenues Despite A 34% Share Price Rise

Nov 22
There's No Escaping Panacea Biotec Limited's (NSE:PANACEABIO) Muted Revenues Despite A 34% Share Price Rise

There's No Escaping Panacea Biotec Limited's (NSE:PANACEABIO) Muted Revenues Despite A 40% Share Price Rise

Oct 03
There's No Escaping Panacea Biotec Limited's (NSE:PANACEABIO) Muted Revenues Despite A 40% Share Price Rise

Most Shareholders Will Probably Find That The Compensation For Panacea Biotec Limited's (NSE:PANACEABIO) CEO Is Reasonable

Sep 21
Most Shareholders Will Probably Find That The Compensation For Panacea Biotec Limited's (NSE:PANACEABIO) CEO Is Reasonable

Panacea Biotec Limited (NSE:PANACEABIO) Held Back By Insufficient Growth Even After Shares Climb 25%

Aug 19
Panacea Biotec Limited (NSE:PANACEABIO) Held Back By Insufficient Growth Even After Shares Climb 25%

Does Panacea Biotec (NSE:PANACEABIO) Have A Healthy Balance Sheet?

Jun 05
Does Panacea Biotec (NSE:PANACEABIO) Have A Healthy Balance Sheet?

Why Investors Shouldn't Be Surprised By Panacea Biotec Limited's (NSE:PANACEABIO) Low P/S

Apr 04
Why Investors Shouldn't Be Surprised By Panacea Biotec Limited's (NSE:PANACEABIO) Low P/S

Why We Think Panacea Biotec Limited's (NSE:PANACEABIO) CEO Compensation Is Not Excessive At All

Sep 23
Why We Think Panacea Biotec Limited's (NSE:PANACEABIO) CEO Compensation Is Not Excessive At All

Estimating The Fair Value Of Panacea Biotec Limited (NSE:PANACEABIO)

Jul 28
Estimating The Fair Value Of Panacea Biotec Limited (NSE:PANACEABIO)

How Does Panacea Biotec's (NSE:PANACEABIO) CEO Pay Compare With Company Performance?

Feb 14
How Does Panacea Biotec's (NSE:PANACEABIO) CEO Pay Compare With Company Performance?

Introducing Panacea Biotec (NSE:PANACEABIO), A Stock That Climbed 80% In The Last Five Years

Jan 06
Introducing Panacea Biotec (NSE:PANACEABIO), A Stock That Climbed 80% In The Last Five Years

Is Panacea Biotec (NSE:PANACEABIO) Using Too Much Debt?

Sep 17
Is Panacea Biotec (NSE:PANACEABIO) Using Too Much Debt?

If You Had Bought Panacea Biotec (NSE:PANACEABIO) Stock A Year Ago, You Could Pocket A 78% Gain Today

Aug 03
If You Had Bought Panacea Biotec (NSE:PANACEABIO) Stock A Year Ago, You Could Pocket A 78% Gain Today

Financial Position Analysis

Short Term Liabilities: PANACEABIO's short term assets (₹5.0B) exceed its short term liabilities (₹3.3B).

Long Term Liabilities: PANACEABIO's short term assets (₹5.0B) exceed its long term liabilities (₹863.5M).


Debt to Equity History and Analysis

Debt Level: PANACEABIO has more cash than its total debt.

Reducing Debt: PANACEABIO's debt to equity ratio has reduced from 281.1% to 2.6% over the past 5 years.

Debt Coverage: PANACEABIO's debt is well covered by operating cash flow (114.4%).

Interest Coverage: Insufficient data to determine if PANACEABIO's interest payments on its debt are well covered by EBIT.


Balance Sheet


Discover healthy companies